Shares of Johnson Matthey PLC (LON:JMAT - Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1,404.68 ($18.86) and traded as high as GBX 1,740 ($23.36). Johnson Matthey shares last traded at GBX 1,737 ($23.32), with a volume of 2,414,905 shares traded.
Johnson Matthey Trading Up 0.5%
The company has a 50 day moving average of GBX 1,447.92 and a two-hundred day moving average of GBX 1,404.68. The company has a debt-to-equity ratio of 62.73, a quick ratio of 0.76 and a current ratio of 1.45. The stock has a market capitalization of £2.90 billion, a PE ratio of 29.52, a P/E/G ratio of 49,242.50 and a beta of 0.95.
Johnson Matthey (LON:JMAT - Get Free Report) last posted its quarterly earnings results on Thursday, May 22nd. The company reported GBX 149.20 ($2.00) earnings per share for the quarter. Johnson Matthey had a return on equity of 4.49% and a net margin of 0.84%. Sell-side analysts predict that Johnson Matthey PLC will post 173.4112903 EPS for the current year.
Johnson Matthey Increases Dividend
The business also recently disclosed a dividend, which was paid on Wednesday, April 16th. Stockholders of record on Thursday, April 10th were issued a GBX 32 ($0.43) dividend. This represents a dividend yield of 1.88%. The ex-dividend date was Thursday, April 10th. This is a boost from Johnson Matthey's previous dividend of $22.00. Johnson Matthey's payout ratio is 130.84%.
Insider Activity
In other Johnson Matthey news, insider Liam Condon purchased 30 shares of the stock in a transaction on Wednesday, April 16th. The shares were bought at an average price of GBX 1,200 ($16.11) per share, for a total transaction of £360 ($483.29). Insiders own 0.61% of the company's stock.
Johnson Matthey Company Profile
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
